Uso de vasopresores en anestesia para pacientes críticos: revisión de la evidencia reciente (2022 – 2025)
ACTAS PERUANAS DE ANESTESIOLOGIA · 30.12.2025 · 23 (2) · 23-31
DOI: 10.65016/m8grzd49 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTAS PERUANAS DE ANESTESIOLOGIA, online erschienen am 30.12.2025. Verfasst von Gabriel Escallon Caballero. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Intraoperative hypotension is a common complication in critically ill patients undergoing anesthetic procedures and is associated with a significant increase in perioperative morbidity and mortality. Vasopressors represent an essential therapeutic tool to maintain mean arterial pressure (MAP) within safe ranges and ensure effective tissue perfusion.
Objective
To describe the most recent scientific evidence on the use of vasopressors in anesthesia for critically ill patients, analyzing their mechanisms of action, clinical indications, dosing strategies, adverse effects, and combined approaches across different types of shock.
Methods
A structured narrative review of the literature published between 2022 and 2025 was conducted using PubMed, Scopus, and the Cochrane Library. Clinical trials, systematic reviews/meta-analyses, and relevant guidelines addressing the perioperative use of vasopressors in critically ill adult patients were included. Due to methodological heterogeneity among studies, a qualitative synthesis was performed.
Results
Norepinephrine remains the first-line vasopressor in septic shock and perioperative hypotension, while vasopressin acts as an adjunct in refractory cases. Epinephrine and dopamine maintain specific indications in cardiogenic and hemorrhagic shock. The evidence highlights the importance of invasive hemodynamic monitoring and the use of perfusion assessment tools to individualize therapy.
Conclusion
Rational, monitored, and evidence-based use of vasopressors in anesthesia for critically ill patients optimizes hemodynamic stability, improves tissue perfusion, and contributes to patient safety.
Zitieren
APA
Caballero, G. E. (2025). Uso de vasopresores en anestesia para pacientes críticos: revisión de la evidencia reciente (2022 – 2025). ACTAS PERUANAS DE ANESTESIOLOGIA, 23(2), 23-31. https://doi.org/10.65016/m8grzd49
Vancouver
Caballero GE. Uso de vasopresores en anestesia para pacientes críticos: revisión de la evidencia reciente (2022 – 2025). ACTAS PERUANAS DE ANESTESIOLOGIA. 2025;23(2):23-31. doi:10.65016/m8grzd49
BibTeX
@article{Caballero2025,
author = {Caballero, Gabriel Escallon},
title = {Uso de vasopresores en anestesia para pacientes críticos: revisión de la evidencia reciente (2022 – 2025)},
journal = {ACTAS PERUANAS DE ANESTESIOLOGIA},
year = {2025},
volume = {23},
number = {2},
pages = {23--31},
doi = {10.65016/m8grzd49}
}
EUVIMED